Mark Kačar
Impact in
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- COVID-19 Clinical Research Studies 11
-
- Immunodeficiency and Autoimmune Disorders 5
- Mast cells and histamine 3
- T-cell and B-cell Immunology 2
- interferon and immune responses 1
- Co-authors
- Sinisa Savic (12 shared papers)Jeroen C.H. van der Hilst (1 shared paper)Shelly Pathak (2 shared papers)Peter Korošec (2 shared papers)Julij Šelb (2 shared papers)Dennis McGonagle (2 shared papers)Matija Rijavec (1 shared paper)Andrew Gough (1 shared paper)
- Journals
- The Lancet (6 papers)Journal of Clinical Immunology (2 papers)Lara D. Veeken (2 papers)Frontiers in Immunology (2 papers)EClinicalMedicine (1 paper)
- Partner nations
- United KingdomSloveniaBelgium
In The Last Decade
Mark Kačar
27 papers receiving 1.8k citations
Mark Kačar's Hit Papers
Peers
Comparison fields: 5 of 86
- Infectious Diseases 1.3k
- Applied Microbiology and Biotechnology 35
- Internal Medicine 27
- Hematology 93
- Immunology 102
Countries citing papers authored by Mark Kačar
This map shows the geographic impact of Mark Kačar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Kačar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Kačar more than expected).
Fields of papers citing papers by Mark Kačar
This network shows the impact of papers produced by Mark Kačar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Kačar. The network helps show where Mark Kačar may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Kačar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 2 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 393 |
| 3 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 4 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 231 |
| 5 | 2021 | 213 | |
| 6 | Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2023 | 84 |
| 7 | 2021 | 32 | |
| 8 | 2020 | 27 | |
| 9 | 2023 | 27 | |
| 10 | 2020 | 25 | |
| 11 | 2023 | 25 | |
| 12 | 2024 | 24 | |
| 13 | 2019 | 20 | |
| 14 | 2024 | 18 | |
| 15 | 2020 | 10 | |
| 16 | 2021 | 10 | |
| 17 | 2020 | 7 | |
| 18 | 2021 | 6 | |
| 19 | 2025 | 6 | |
| 20 | 2018 | 5 |
About Mark Kačar
Mark Kačar is a scholar working on Infectious Diseases, Immunology, Hematology, Immunology and Allergy and Molecular Biology, having authored 28 papers that have together received 1.9k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (11 papers), Immunodeficiency and Autoimmune Disorders (5 papers), Inflammasome and immune disorders (4 papers), Mast cells and histamine (3 papers), T-cell and B-cell Immunology (2 papers), Acute Myeloid Leukemia Research (1 paper), Kawasaki Disease and Coronary Complications (1 paper) and interferon and immune responses (1 paper). The work is most often cited by research in Infectious Diseases (1.3k citations), Applied Microbiology and Biotechnology (35 citations), Internal Medicine (27 citations), Hematology (93 citations) and Immunology (102 citations). Mark Kačar has collaborated with scholars based in United Kingdom, Slovenia and Belgium. Frequent co-authors include Sinisa Savic, Jeroen C.H. van der Hilst, Shelly Pathak, Peter Korošec, Julij Šelb, Dennis McGonagle, Matija Rijavec, Andrew Gough, Maya H Buch and John M. Fitton. Their work appears in journals such as The Lancet, Journal of Clinical Immunology, Lara D. Veeken, Frontiers in Immunology and EClinicalMedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.